tetano
Editor, Senior Moderator
J Chin Med Assoc. 2011 Jun;74(6):280-2. Epub 2011 May 12.
Pityriasis rosea following influenza (H1N1) vaccination.
Chen JF, Chiang CP, Chen YF, Wang WM.
Source
Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Abstract
Pityriasis rosea is a distinct papulosquamous skin eruption that has been attributed to viral reactivation, certain drug exposures or rarely, vaccination. Herein, we reported a clinicopathlogically typical case of pityriasis rosea that developed after the H1N1 vaccination. With a global H1N1 vaccination program against the pandemic H1N1 influenza, patients should be apprised of the possibility of such rare but benign skin reaction to avoid unnecessary fear. Furthermore, a brief review of the current reported skin adverse events related to the novel H1N1 vaccination in Taiwan is presented here.
Copyright ? 2011. Published by Elsevier B.V.
PMID:
21621174
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21621174
Pityriasis rosea following influenza (H1N1) vaccination.
Chen JF, Chiang CP, Chen YF, Wang WM.
Source
Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Abstract
Pityriasis rosea is a distinct papulosquamous skin eruption that has been attributed to viral reactivation, certain drug exposures or rarely, vaccination. Herein, we reported a clinicopathlogically typical case of pityriasis rosea that developed after the H1N1 vaccination. With a global H1N1 vaccination program against the pandemic H1N1 influenza, patients should be apprised of the possibility of such rare but benign skin reaction to avoid unnecessary fear. Furthermore, a brief review of the current reported skin adverse events related to the novel H1N1 vaccination in Taiwan is presented here.
Copyright ? 2011. Published by Elsevier B.V.
PMID:
21621174
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21621174